According to the Fortune Business Insights, The protein sequencing market was valued at USD 1.34 billion in 2025 and is estimated to reach USD 1.47 billion in 2026. It is projected to reach USD 3.15 billion by 2034, exhibiting a CAGR of 10.0% during the forecast period.

The growing prevalence of chronic diseases, expanding pharmaceutical and biotechnology industries, and rising government funding for proteomics research continue to support the expansion of the protein sequencing market. Furthermore, increasing collaborations between academic institutions, research organizations, and biotechnology companies are accelerating innovation and driving the commercialization of advanced protein sequencing technologies. As demand for biomarker discovery and targeted therapeutics continues to grow, the protein sequencing market is expected to remain a key segment within the global life sciences industry.

Continue reading for more details:

https://www.fortunebusinessinsights.com/protein-sequencing-marke-114978

Market Segmentation

The protein sequencing market is segmented by product, application, end user, and region. Based on product, the market includes instruments, consumables and reagents, and software. Consumables and reagents account for the largest market share owing to their recurring usage in protein sequencing workflows across research laboratories and pharmaceutical companies. By application, the protein sequencing market is categorized into drug discovery and development, clinical diagnostics, genetic engineering, academic research, and others. Drug discovery and development dominate the application segment as pharmaceutical companies increasingly utilize protein sequencing technologies to identify therapeutic targets and improve biologic drug development. Based on end user, the protein sequencing market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations, and hospitals and diagnostic laboratories. Pharmaceutical and biotechnology companies represent the largest end-user segment due to growing investments in biologics, biosimilars, and precision medicine research. The increasing adoption of advanced analytical platforms across diverse research applications continues to strengthen the long-term growth potential of the protein sequencing market.

Key Players

• Thermo Fisher Scientific Inc.
• Agilent Technologies, Inc.
• Bruker Corporation
• Shimadzu Corporation
• Bio-Rad Laboratories, Inc.
• Waters Corporation
• SCIEX
• Danaher Corporation
• SGS SA
• Rapid Novor Inc.

Market Growth

The protein sequencing market is expected to experience significant growth throughout the forecast period due to increasing research activities focused on understanding complex biological processes and disease mechanisms. The rapid expansion of precision medicine initiatives worldwide has created substantial demand for advanced protein sequencing technologies capable of identifying disease-specific biomarkers and therapeutic targets. Pharmaceutical and biotechnology companies continue to increase investments in biologic drug development, monoclonal antibodies, vaccines, and cell and gene therapies, further supporting the growth of the protein sequencing market. Technological advancements in mass spectrometry, Edman degradation techniques, artificial intelligence-assisted data analysis, and high-throughput sequencing platforms have significantly improved sequencing accuracy, speed, and efficiency. Growing government funding for life sciences research and rising collaborations between research institutions and industry participants continue to accelerate innovation. The expanding use of protein sequencing in cancer research, infectious disease studies, immunology, neuroscience, and rare disease investigations further contributes to market expansion. Additionally, increasing demand for contract research services and laboratory automation is enabling organizations to conduct large-scale proteomics studies more efficiently. These developments are expected to create numerous growth opportunities for the protein sequencing market throughout the coming years.

Restraining Factors

Despite its strong growth outlook, the protein sequencing market faces several challenges that may restrict market expansion. One of the major restraints is the high cost associated with advanced protein sequencing instruments, laboratory infrastructure, and maintenance, making adoption difficult for smaller research organizations and institutions with limited budgets. The complexity of protein sequencing workflows requires highly skilled professionals capable of operating sophisticated analytical instruments and interpreting complex datasets, creating a shortage of experienced personnel in certain regions. Data analysis remains another significant challenge due to the enormous volume of proteomics data generated during sequencing experiments. In addition, sample preparation procedures are often time-consuming and require specialized reagents and standardized laboratory protocols. Regulatory requirements for clinical applications and validation of sequencing technologies may delay product commercialization and increase development costs. Competition from alternative analytical techniques and evolving molecular diagnostic technologies also presents challenges for manufacturers. Furthermore, fluctuations in research funding and economic uncertainties may influence purchasing decisions by academic institutions and research laboratories, affecting the overall growth of the protein sequencing market.

Regional Analysis

North America dominated the protein sequencing market in 2025 and continues to maintain its leadership position in 2026 owing to substantial investments in biomedical research, advanced healthcare infrastructure, strong pharmaceutical and biotechnology industries, and the presence of leading proteomics technology providers. The United States remains the largest contributor due to extensive government funding, increasing research collaborations, and growing adoption of precision medicine initiatives. Europe represents the second-largest regional market, supported by expanding life sciences research, favorable government funding programs, and increasing investments in biotechnology innovation across Germany, the United Kingdom, France, and other European countries. Asia Pacific is expected to register the fastest growth during the forecast period due to rapidly expanding biotechnology industries, increasing healthcare expenditure, growing pharmaceutical manufacturing capabilities, and rising investments in research infrastructure across China, Japan, India, and South Korea. Governments throughout the region are actively supporting genomic and proteomic research programs, creating new opportunities for market participants. Latin America and the Middle East & Africa are also expected to witness steady growth as healthcare infrastructure improves, research capabilities expand, and awareness regarding advanced proteomics technologies continues to increase. These regional developments, combined with continuous technological innovation and increasing global research activities, are expected to drive sustained growth in the protein sequencing market throughout the forecast period.